Inga, Alberto

The expanding universe of p53 targets

Menendez, D., Inga, A., & Resnick, M. A. (2009) · Nature Reviews Cancer

Cancer-related Molecular PathwaysGenomics and Chromatin Dynamics

Cited by 568

A highly specific SpCas9 variant is identified by in vivo screening in yeast

Casini, A., Olivieri, M., Petris, G., Montagna, C., Reginato, G., Maule, G., Lorenzin, F., Prandi, D., Romanel, A., Demichelis, F., et al. (2018) · Nature Biotechnology

CRISPR and Genetic EngineeringRNA regulation and disease

Cited by 493

The TP53 website: An integrative resource centre for the TP53 mutation database and TP53 mutant analysis

Leroy, B., Fournier, J. L., Ishioka, C., Monti, P., Inga, A., Fronza, G., & Soussi, T. (2013) · Nucleic Acids Research

Cancer-related Molecular PathwaysCancer Genomics and Diagnostics

Cited by 185

Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity

Resnick, M. A., & Inga, A. (2003) · Proceedings of the National Academy of Sciences

Cancer-related Molecular PathwaysGenomics and Chromatin Dynamics

Cited by 149

Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53

Jordan, J. J., Menendez, D., Inga, A., Nourredine, M., Bell, D., & Resnick, M. A. (2008) · PLoS Genetics

Cancer-related Molecular PathwaysGenomics and Chromatin Dynamics

Cited by 103

SMN-primed ribosomes modulate the translation of transcripts related to spinal muscular atrophy

Lauria, F., Bernabò, P., Tebaldi, T., Groen, E. J. N., Perenthaler, E., Maniscalco, F., Rossi, A., Donzel, D., Clamer, M., Marchioretto, M., et al. (2020) · Nature Cell Biology

RNA and protein synthesis mechanismsNeurogenetic and Muscular Disorders Research

Cited by 98

SMN-primed ribosomes modulate the translation of transcripts related to Spinal Muscular Atrophy

Lauria, F., Bernabò, P., Tebaldi, T., Groen, E., Perenthaler, E., Clamer, M., Maniscalco, F., Marchioretto, M., Orri, J., Dalla Serra, M., et al. (2019) · Nature Cell Biology

RNA and protein synthesis mechanismsNeurogenetic and Muscular Disorders Research

Cited by 98

The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes

Menendez, D., Inga, A., & Resnick, M. A. (2006) · Molecular and Cellular Biology

Cancer-related Molecular PathwaysCell death mechanisms and regulation

Cited by 81

Whole-genome cartography of p53 response elements ranked on transactivation potential

Tebaldi, T., Zaccara, S., Alessandrini, F., Bisio, A., Ciribilli, Y., & Inga, A. (2015) · BMC Genomics

Cancer-related Molecular PathwaysGenomics and Chromatin Dynamics

Cited by 72

Transcriptional functionality of germ line p53 mutants influences cancer phenotype

Monti, P., Ciribilli, Y., Jordan, J., Menichini, P., Umbach, D. M., Resnick, M. A., Luzzatto, L., Inga, A., & Fronza, G. (2007) · Clinical Cancer Research

Cancer-related Molecular PathwaysGenetic factors in colorectal cancer

Cited by 58

Inherited determinants of early recurrent somatic mutations in prostate cancer

Romanel, A., Garritano, S., Stringa, B., Blattner, M., Dalfovo, D., Chakravarty, D., Soong, D., Cotter, K. A., Petris, G., Dhingra, P., et al. (2017) · Nature Communications

Prostate Cancer Treatment and ResearchChromatin Remodeling and Cancer

Cited by 29